Carlo Traverso
Fondatore presso Lyndra Therapeutics, Inc.
Posizioni attive di Carlo Traverso
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Direttore/Membro del Consiglio | 01/01/2015 | - |
Fondatore | 01/01/2015 | - | |
Suono Bio, Inc.
Suono Bio, Inc. Medical SpecialtiesHealth Technology Suono Bio, Inc. develops therapeutics to the gastrointestinal tract which helps to cure diseases. The company was founded by Carl Schoellhammer, Robert S. Langer Jr., Amy W. Schulman, and Giovanni Traverso and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Celero Systems, Inc.
Celero Systems, Inc. BiotechnologyHealth Technology Celero Systems, Inc. is a life science company. It develops ingestible system to detect and reverse opioid overdose. The company was founded by Benjamin D. Pless, Carlo Giovanni Traverso, Robert S. Langer Jr., and Jeremy N. Ruskin and is headquartered in Lincoln, MA. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Teal Bio, Inc.
Teal Bio, Inc. Medical SpecialtiesHealth Technology Teal Bio, Inc. is a developer of innovative, reusable respiratory personal protective equipment. The company is based in Somerville, MA, and operates out of Greentown Labs, the largest climatetech incubator in the area. The company's patent-pending reusable mask and filter platform reduces waste, improves communication, and is more comfortable than existing N95 solutions. The company was founded by Carlo Giovanni Traverso, Jason Troutner, Robert S. Langer, James Byrne, Adam Wentworth. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investitore di Private Equity | - | - |
Syntis Bio, Inc.
Syntis Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Syntis Bio, Inc. is a company that creates simple oral therapies and treatments targeting specific tissues through novel formulations. The company is based in Milton, MA. Rahul scaled the company by building a diverse and accomplished team to reach commercialization of the first-ever CRISPR product, diagnostic or therapeutic, to be authorized by the FDA. The company is committed to equity, excellence, and diversity, and is building a culture that supports its team to grow, take risks, and achieve individual goals. It was founded by Carlo Giovanni Traverso, Robert S. Langer, and Rahul K. Dhanda, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - | |
Vivtex Corp. | Direttore/Membro del Consiglio | - | - |
Fondatore | - | - |
Storia della carriera di Carlo Traverso
Formazione di Carlo Traverso
University of Cambridge | Doctorate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 6 |
Founder | 6 |
Doctorate Degree | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Technology Services |
Suono Bio, Inc.
Suono Bio, Inc. Medical SpecialtiesHealth Technology Suono Bio, Inc. develops therapeutics to the gastrointestinal tract which helps to cure diseases. The company was founded by Carl Schoellhammer, Robert S. Langer Jr., Amy W. Schulman, and Giovanni Traverso and is headquartered in Cambridge, MA. | Health Technology |
Celero Systems, Inc.
Celero Systems, Inc. BiotechnologyHealth Technology Celero Systems, Inc. is a life science company. It develops ingestible system to detect and reverse opioid overdose. The company was founded by Benjamin D. Pless, Carlo Giovanni Traverso, Robert S. Langer Jr., and Jeremy N. Ruskin and is headquartered in Lincoln, MA. | Health Technology |
Vivtex Corp. | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Teal Bio, Inc.
Teal Bio, Inc. Medical SpecialtiesHealth Technology Teal Bio, Inc. is a developer of innovative, reusable respiratory personal protective equipment. The company is based in Somerville, MA, and operates out of Greentown Labs, the largest climatetech incubator in the area. The company's patent-pending reusable mask and filter platform reduces waste, improves communication, and is more comfortable than existing N95 solutions. The company was founded by Carlo Giovanni Traverso, Jason Troutner, Robert S. Langer, James Byrne, Adam Wentworth. | Health Technology |
Syntis Bio, Inc.
Syntis Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Syntis Bio, Inc. is a company that creates simple oral therapies and treatments targeting specific tissues through novel formulations. The company is based in Milton, MA. Rahul scaled the company by building a diverse and accomplished team to reach commercialization of the first-ever CRISPR product, diagnostic or therapeutic, to be authorized by the FDA. The company is committed to equity, excellence, and diversity, and is building a culture that supports its team to grow, take risks, and achieve individual goals. It was founded by Carlo Giovanni Traverso, Robert S. Langer, and Rahul K. Dhanda, who has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Carlo Traverso
- Esperienza